A detailed history of Teton Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Teton Advisors, LLC holds 53,100 shares of NEO stock, worth $549,054. This represents 0.25% of its overall portfolio holdings.

Number of Shares
53,100
Holding current value
$549,054
% of portfolio
0.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$4.84 - $8.81 $257,004 - $467,811
53,100 New
53,100 $410 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.3B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Teton Advisors, LLC Portfolio

Follow Teton Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teton Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teton Advisors, LLC with notifications on news.